Article info
PDFLiver
Research
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
- Correspondence to Dr Paola Di Maggio, UK Medical Affairs, Norgine, Moorhall Road, Harefield, Uxbridge, London UB9 6NS, UK; pdimaggio{at}norgine.com
Citation
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
Publication history
- Received December 9, 2016
- Revised March 6, 2017
- Accepted March 17, 2017
- First published April 7, 2017.
Online issue publication
September 11, 2017
Article Versions
- Previous version (11 September 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/